HEADER SIGNALING PROTEIN 26-NOV-11 4A9M TITLE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-CYCLOPENTYL-5-( TITLE 2 3,5-DIMETHYL-1,2-OXAZOL-4-YL)-2-METHYLBENZENE-1- TITLE 3 SULFONAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN CONTAINING 2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: N-TERMINAL BROMODOMAIN (BD1), RESIDUES 67-200; COMPND 5 SYNONYM: HUMAN BRD2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, HISTONE, EPIGENETIC READER, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.CHUNG,P.BAMBOROUGH REVDAT 1 08-FEB-12 4A9M 0 JRNL AUTH P.BAMBOROUGH,H.DIALLO,J.D.GOODACRE,L.GORDON,A.LEWIS, JRNL AUTH 2 J.T.SEAL,D.M.WILSON,M.D.WOODROW,C.W.CHUNG JRNL TITL FRAGMENT-BASED DISCOVERY OF BROMODOMAIN INHIBITORS PART 2: JRNL TITL 2 OPTIMIZATION OF PHENYLISOXAZOLE SULFONAMIDES. JRNL REF J.MED.CHEM. V. 55 587 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22136469 JRNL DOI 10.1021/JM201283Q REMARK 2 REMARK 2 RESOLUTION. 2.06 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.06 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 100.00 REMARK 3 NUMBER OF REFLECTIONS : 25297 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.18267 REMARK 3 R VALUE (WORKING SET) : 0.18030 REMARK 3 FREE R VALUE : 0.22464 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1345 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.060 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.113 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1833 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.278 REMARK 3 BIN FREE R VALUE SET COUNT : 89 REMARK 3 BIN FREE R VALUE : 0.294 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2846 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 312 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.134 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.50 REMARK 3 B22 (A**2) : -1.97 REMARK 3 B33 (A**2) : -0.78 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : -1.59 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.194 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.169 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.128 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.813 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3015 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4102 ; 1.139 ; 1.946 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 346 ; 4.606 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 143 ;38.082 ;25.035 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 541 ;13.337 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;24.083 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 425 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2278 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1721 ; 1.092 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2809 ; 2.089 ; 4.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1294 ; 2.451 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1293 ; 3.714 ; 6.000 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 4A9M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-NOV-11. REMARK 100 THE PDBE ID CODE IS EBI-50492. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FRE SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD (SATURN A200) REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26642 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.06 REMARK 200 RESOLUTION RANGE LOW (A) : 33.88 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NONE REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.5 REMARK 200 R MERGE (I) : 0.08 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.50 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.06 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 33.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.4 REMARK 200 R MERGE FOR SHELL (I) : 0.37 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.20 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES, PH 8.5, 24-34% REMARK 280 PEG 3350, 0.2 M (NH4)2SO4. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.78850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.84100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.78850 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.84100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -5.46423 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 67.76606 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 47 REMARK 465 SER A 48 REMARK 465 SER A 49 REMARK 465 HIS A 50 REMARK 465 HIS A 51 REMARK 465 HIS A 52 REMARK 465 HIS A 53 REMARK 465 HIS A 54 REMARK 465 HIS A 55 REMARK 465 SER A 56 REMARK 465 SER A 57 REMARK 465 GLY A 58 REMARK 465 LEU A 59 REMARK 465 VAL A 60 REMARK 465 PRO A 61 REMARK 465 ARG A 62 REMARK 465 GLY A 63 REMARK 465 SER A 64 REMARK 465 HIS A 65 REMARK 465 MET A 66 REMARK 465 SER A 67 REMARK 465 ASN A 68 REMARK 465 PRO A 69 REMARK 465 LYS A 70 REMARK 465 LYS A 71 REMARK 465 PRO A 72 REMARK 465 GLY A 73 REMARK 465 ARG A 74 REMARK 465 LEU A 187 REMARK 465 VAL A 188 REMARK 465 VAL A 189 REMARK 465 THR A 190 REMARK 465 ILE A 191 REMARK 465 PRO A 192 REMARK 465 LYS A 193 REMARK 465 ASN A 194 REMARK 465 SER A 195 REMARK 465 HIS A 196 REMARK 465 LYS A 197 REMARK 465 LYS A 198 REMARK 465 GLY A 199 REMARK 465 ALA A 200 REMARK 465 GLY B 47 REMARK 465 SER B 48 REMARK 465 SER B 49 REMARK 465 HIS B 50 REMARK 465 HIS B 51 REMARK 465 HIS B 52 REMARK 465 HIS B 53 REMARK 465 HIS B 54 REMARK 465 HIS B 55 REMARK 465 SER B 56 REMARK 465 SER B 57 REMARK 465 GLY B 58 REMARK 465 LEU B 59 REMARK 465 VAL B 60 REMARK 465 PRO B 61 REMARK 465 ARG B 62 REMARK 465 GLY B 63 REMARK 465 SER B 64 REMARK 465 HIS B 65 REMARK 465 MET B 66 REMARK 465 SER B 67 REMARK 465 ASN B 68 REMARK 465 PRO B 69 REMARK 465 LYS B 70 REMARK 465 LYS B 71 REMARK 465 PRO B 72 REMARK 465 LEU B 187 REMARK 465 VAL B 188 REMARK 465 VAL B 189 REMARK 465 THR B 190 REMARK 465 ILE B 191 REMARK 465 PRO B 192 REMARK 465 LYS B 193 REMARK 465 ASN B 194 REMARK 465 SER B 195 REMARK 465 HIS B 196 REMARK 465 LYS B 197 REMARK 465 LYS B 198 REMARK 465 GLY B 199 REMARK 465 ALA B 200 REMARK 465 GLY C 47 REMARK 465 SER C 48 REMARK 465 SER C 49 REMARK 465 HIS C 50 REMARK 465 HIS C 51 REMARK 465 HIS C 52 REMARK 465 HIS C 53 REMARK 465 HIS C 54 REMARK 465 HIS C 55 REMARK 465 SER C 56 REMARK 465 SER C 57 REMARK 465 GLY C 58 REMARK 465 LEU C 59 REMARK 465 VAL C 60 REMARK 465 PRO C 61 REMARK 465 ARG C 62 REMARK 465 GLY C 63 REMARK 465 SER C 64 REMARK 465 HIS C 65 REMARK 465 MET C 66 REMARK 465 SER C 67 REMARK 465 ASN C 68 REMARK 465 PRO C 69 REMARK 465 LYS C 70 REMARK 465 LYS C 71 REMARK 465 PRO C 72 REMARK 465 GLY C 73 REMARK 465 ARG C 74 REMARK 465 VAL C 75 REMARK 465 GLU C 183 REMARK 465 GLU C 184 REMARK 465 GLN C 185 REMARK 465 GLU C 186 REMARK 465 LEU C 187 REMARK 465 VAL C 188 REMARK 465 VAL C 189 REMARK 465 THR C 190 REMARK 465 ILE C 191 REMARK 465 PRO C 192 REMARK 465 LYS C 193 REMARK 465 ASN C 194 REMARK 465 SER C 195 REMARK 465 HIS C 196 REMARK 465 LYS C 197 REMARK 465 LYS C 198 REMARK 465 GLY C 199 REMARK 465 ALA C 200 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU B 183 CG CD OE1 OE2 REMARK 470 GLN C 182 CG CD OE1 NE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 MET A 123 CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH C 2060 O HOH C 2060 2556 1.46 REMARK 500 O HOH C 2068 O HOH C 2068 2556 1.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 184 99.71 -69.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C2070 DISTANCE = 8.03 ANGSTROMS REMARK 525 HOH C2071 DISTANCE = 6.53 ANGSTROMS REMARK 525 HOH C2072 DISTANCE = 9.82 ANGSTROMS REMARK 525 HOH C2073 DISTANCE = 5.09 ANGSTROMS REMARK 525 HOH C2076 DISTANCE = 7.27 ANGSTROMS REMARK 525 HOH C2077 DISTANCE = 6.37 ANGSTROMS REMARK 525 HOH C2078 DISTANCE = 6.60 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P9M A1187 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1188 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1189 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P9M B1187 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P9M C1183 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C1184 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2YEK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN REMARK 900 BRD2 WITH THE INHIBITOR GSK525762 (IBET) REMARK 900 RELATED ID: 4A9E RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1 REMARK 900 ,2,3,4-TETRAHYDROQUINAZOLIN-2-ONE REMARK 900 RELATED ID: 1X0J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE N-TERMINAL BROMODOMAIN REMARK 900 OFHUMAN BRD2 REMARK 900 RELATED ID: 4A9F RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1- REMARK 900 METHYLPYRROLIDIN-2-ONE REMARK 900 RELATED ID: 2YDW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN REMARK 900 BRD2 WITH THE INHIBITOR GW841819X REMARK 900 RELATED ID: 4A9J RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(4- REMARK 900 HYDROXYPHENYL)ACETAMIDE REMARK 900 RELATED ID: 4A9I RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1 REMARK 900 ,2,3,4-TETRAHYDROQUINAZOLIN-2-ONE DBREF 4A9M A 67 200 UNP P25440 BRD2_HUMAN 67 200 DBREF 4A9M B 67 200 UNP P25440 BRD2_HUMAN 67 200 DBREF 4A9M C 67 200 UNP P25440 BRD2_HUMAN 67 200 SEQADV 4A9M GLY A 47 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER A 48 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER A 49 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS A 50 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS A 51 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS A 52 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS A 53 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS A 54 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS A 55 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER A 56 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER A 57 UNP P25440 EXPRESSION TAG SEQADV 4A9M GLY A 58 UNP P25440 EXPRESSION TAG SEQADV 4A9M LEU A 59 UNP P25440 EXPRESSION TAG SEQADV 4A9M VAL A 60 UNP P25440 EXPRESSION TAG SEQADV 4A9M PRO A 61 UNP P25440 EXPRESSION TAG SEQADV 4A9M ARG A 62 UNP P25440 EXPRESSION TAG SEQADV 4A9M GLY A 63 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER A 64 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS A 65 UNP P25440 EXPRESSION TAG SEQADV 4A9M MET A 66 UNP P25440 EXPRESSION TAG SEQADV 4A9M GLY B 47 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER B 48 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER B 49 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS B 50 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS B 51 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS B 52 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS B 53 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS B 54 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS B 55 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER B 56 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER B 57 UNP P25440 EXPRESSION TAG SEQADV 4A9M GLY B 58 UNP P25440 EXPRESSION TAG SEQADV 4A9M LEU B 59 UNP P25440 EXPRESSION TAG SEQADV 4A9M VAL B 60 UNP P25440 EXPRESSION TAG SEQADV 4A9M PRO B 61 UNP P25440 EXPRESSION TAG SEQADV 4A9M ARG B 62 UNP P25440 EXPRESSION TAG SEQADV 4A9M GLY B 63 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER B 64 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS B 65 UNP P25440 EXPRESSION TAG SEQADV 4A9M MET B 66 UNP P25440 EXPRESSION TAG SEQADV 4A9M GLY C 47 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER C 48 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER C 49 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS C 50 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS C 51 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS C 52 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS C 53 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS C 54 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS C 55 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER C 56 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER C 57 UNP P25440 EXPRESSION TAG SEQADV 4A9M GLY C 58 UNP P25440 EXPRESSION TAG SEQADV 4A9M LEU C 59 UNP P25440 EXPRESSION TAG SEQADV 4A9M VAL C 60 UNP P25440 EXPRESSION TAG SEQADV 4A9M PRO C 61 UNP P25440 EXPRESSION TAG SEQADV 4A9M ARG C 62 UNP P25440 EXPRESSION TAG SEQADV 4A9M GLY C 63 UNP P25440 EXPRESSION TAG SEQADV 4A9M SER C 64 UNP P25440 EXPRESSION TAG SEQADV 4A9M HIS C 65 UNP P25440 EXPRESSION TAG SEQADV 4A9M MET C 66 UNP P25440 EXPRESSION TAG SEQRES 1 A 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 A 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 A 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 A 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 A 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 A 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 A 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 A 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 A 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 A 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 A 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 A 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA SEQRES 1 B 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 B 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 B 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 B 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 B 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 B 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 B 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 B 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 B 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 B 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 B 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 B 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA SEQRES 1 C 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 C 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 C 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 C 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 C 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 C 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 C 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 C 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 C 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 C 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 C 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 C 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA HET P9M A1187 23 HET SO4 A1188 5 HET SO4 A1189 5 HET P9M B1187 23 HET P9M C1183 23 HET SO4 C1184 5 HETNAM P9M N-CYCLOPENTYL-5-(3,5-DIMETHYLISOXAZOL-4-YL)- HETNAM 2 P9M 2-METHYLBENZENESULFONAMIDE HETNAM SO4 SULFATE ION FORMUL 4 P9M 3(C17 H22 N2 O3 S) FORMUL 5 SO4 3(O4 S 2-) FORMUL 6 HOH *312(H2 O) HELIX 1 1 THR A 76 VAL A 85 1 10 HELIX 2 2 VAL A 85 LYS A 92 1 8 HELIX 3 3 ALA A 96 ARG A 100 5 5 HELIX 4 4 ASP A 112 ILE A 117 1 6 HELIX 5 5 ASP A 122 ASN A 132 1 11 HELIX 6 6 ALA A 137 ASN A 156 1 20 HELIX 7 7 ASP A 160 ALA A 178 1 19 HELIX 8 8 THR B 76 VAL B 85 1 10 HELIX 9 9 VAL B 85 HIS B 93 1 9 HELIX 10 10 ALA B 96 ARG B 100 5 5 HELIX 11 11 ASP B 112 ILE B 117 1 6 HELIX 12 12 ASP B 122 ASN B 132 1 11 HELIX 13 13 ALA B 137 ASN B 156 1 20 HELIX 14 14 ASP B 160 SER B 179 1 20 HELIX 15 15 THR C 76 VAL C 85 1 10 HELIX 16 16 VAL C 85 HIS C 93 1 9 HELIX 17 17 ALA C 96 ARG C 100 5 5 HELIX 18 18 ASP C 112 ILE C 117 1 6 HELIX 19 19 ASP C 122 ASN C 132 1 11 HELIX 20 20 ALA C 137 ASN C 156 1 20 HELIX 21 21 ASP C 160 SER C 179 1 20 SITE 1 AC1 10 TRP A 97 PRO A 98 PHE A 99 LEU A 108 SITE 2 AC1 10 LEU A 110 ASN A 156 MET A 165 HOH A2059 SITE 3 AC1 10 HOH A2127 GLN B 94 SITE 1 AC2 3 ARG A 100 HOH A2019 HOH A2021 SITE 1 AC3 3 ARG A 128 ARG A 129 HOH A2131 SITE 1 AC4 9 GLN A 94 TRP B 97 PRO B 98 PHE B 99 SITE 2 AC4 9 LEU B 108 ASN B 156 MET B 165 HOH B2039 SITE 3 AC4 9 HOH B2100 SITE 1 AC5 11 ASN A 77 GLN A 80 TRP C 97 PRO C 98 SITE 2 AC5 11 PHE C 99 LEU C 108 LEU C 110 TYR C 113 SITE 3 AC5 11 TYR C 155 ASN C 156 HOH C2025 SITE 1 AC6 9 ARG B 100 HOH B2012 HOH B2013 ARG C 128 SITE 2 AC6 9 ARG C 129 ASN C 132 TYR C 134 HOH C2043 SITE 3 AC6 9 HOH C2050 CRYST1 115.577 55.682 67.986 90.00 94.61 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008652 0.000000 0.000698 0.00000 SCALE2 0.000000 0.017959 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014757 0.00000